PyIgClassify2: Canonical Clusters of Antibody CDR Loop Conformations

PyIgClassify2: Classification of Antibody CDR Conformations

CDRs for query 7N9V

#CDRs = 4; #Clusters = 4.
Chain	Gene	PDB Species	Frame Germline	Frame %	CDR Germline	CDR %	CDR	Length	Cluster	Distance(°)	Sequence	Ramachandran
B	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	53.8	H1	13	H1-13-5	23	AASGSISRFNAMG	BBBEBAAABABBB
B	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	33.3	H2	9	H2-9-*	-1	RIVKGGYAV	BBBBLBBBB
B	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	50.0	H3	8	H3-8-*	-1	FAALDTAY	BBBBABBB
B	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	50.0	H4	8	H4-8-1	11	IDSAENTL	BBAAALBB
E	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	53.8	H1	13	H1-13-5	23	AASGSISRFNAMG	BBBEBAAABABBB
E	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	33.3	H2	9	H2-9-*	-1	RIVKGGYAV	BBBBLBBBB
E	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	50.0	H3	8	H3-8-*	-1	FAALDTAY	BBBBABBB
E	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	50.0	H4	8	H4-8-1	11	IDSAENTL	BBAAALBB
F	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	53.8	H1	13	H1-13-5	23	AASGSISRFNAMG	BBBEBAAABABBB
F	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	33.3	H2	9	H2-9-*	-1	RIVKGGYAV	BBBBLBBBB
F	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	50.0	H3	8	H3-8-*	-1	FAALDTAY	BBBBABBB
F	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	50.0	H4	8	H4-8-1	11	IDSAENTL	BBAAALBB
H	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	53.8	H1	13	H1-13-5	23	AASGSISRFNAMG	BBBEBAAABABBB
H	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	33.3	H2	9	H2-9-*	-1	RIVKGGYAV	BBBBLBBBB
H	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	50.0	H3	8	H3-8-*	-1	FAALDTAY	BBBBABBB
H	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	50.0	H4	8	H4-8-1	11	IDSAENTL	BBAAALBB
J	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	53.8	H1	13	H1-13-5	23	AASGSISRFNAMG	BBBEBAAABABBB
J	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	33.3	H2	9	H2-9-*	-1	RIVKGGYAV	BBBBLBBBB
J	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	50.0	H3	8	H3-8-*	-1	FAALDTAY	BBBBABBB
J	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	50.0	H4	8	H4-8-1	11	IDSAENTL	BBAAALBB
L	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	53.8	H1	13	H1-13-5	23	AASGSISRFNAMG	BBBEBAAABABBB
L	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	33.3	H2	9	H2-9-*	-1	RIVKGGYAV	BBBBLBBBB
L	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	50.0	H3	8	H3-8-*	-1	FAALDTAY	BBBBABBB
L	heavy	Lama.glama	La_IGHV1S3*01_VHH	86.1	La_IGHV1S3*01_VHH	50.0	H4	8	H4-8-1	11	IDSAENTL	BBAAALBB

Site developed by the Antibody Team at the lab of Roland Dunbrack. Last updated on Oct. 13, 2022